NorthWest Biotherapeutics Inc (NWBO)

[TZOR]

Was just reading last weeks Barron's article, and I noticed the following information

"The Tufts Center for the study of Drug Development reported a year ago that the developing a new prescription drug that gains marketing approval carries average direct out-of-corporate-pocket costs of $1.4 billion (including the cost of drugs that fail) and opportunity cost of $1.1 billion (including the time value of money invested for an average 10 years of development)"

For all those that argue our trial is taking too long, it appears that we are at roughly the average mark, and cost wise we are below the average mark

Food for thought.